Drugs Xagena
Provenge ( Sipuleucel-T ) is an autologous cellular immunotherapy designed to stimulate a patients own immune system against cancer. Provenge is manufactured in several steps. First the patients bl ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use ( CHMP ) has recommended granting a marketing authorisation for a new advanced-therapy medicinal product ( ATMP ). Proven ...
Dendreon has announced that the European Commission ( EC ) has granted marketing authorization for Provenge ( autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or Sipuleucel-T ) ...
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Provenge.The indication rec ...
